Psychedelics Psychedelic Healing Shack goes up for sale, owner sick of conflict with Detroit officials "I don't want to sell, but the city is giving me a hard time," owner Robert Pizzimenti told Detroit Metro Times Rowan DunneApril 25, 2025
Psychedelics Colorado licenses its first magic mushroom therapy clinic 'The Center Origin' is also used for yoga, meditation, reiki, massage and other new age spiritual practices Rowan DunneApril 1, 2025
Psychedelics Colorado students interested in psychedelics gain access to US$1.5M grant Those enrolling at Naropa University who want to do a minor in psychedelics now have more incentive Rowan DunneMarch 4, 2025
Psychedelics 51 Colorado residents become state’s first certified magic mushroom therapists They recently graduated from a psychedelic therapy facilitator program run by InnerTrek Rowan DunneFebruary 12, 2025
Psychedelics Edmonton’s new psychedelic therapy clinic helps residents soothe the winter blues It offers ketamine, psilocybin, and MDMA therapy sessions Rowan DunneJanuary 27, 2025
Psychedelics Not all Oregon cities approve of the state’s magic mushroom laws Four of them voted to implement new bans on usage of the psychedelic compound in the Nov. 5 election Rowan DunneNovember 22, 2024
Psychedelics ATMA CENA opens Alberta psychedelic therapy clinics, Ontario locations to follow The treatment provider is a joint venture between ATMA Journey Centers and Cena Life Rowan DunneMarch 14, 2024
News Numinus Wellness launches psychedelic-assisted therapy program for mental distress due to chronic illness The program includes four key initiatives that showcase Numinus' psychedelic research efforts Natalia Buendia CalvilloOctober 3, 2023
News New research affirms therapists as pivotal for success in psilocybin-assisted therapy The research could have far-reaching implications for the training of therapists and the delivery of psychedelic therapies in clinical settings Natalia Buendia CalvilloAugust 28, 2023
Psychedelics Apex Labs doses first patient in Veterans take-home psilocybin drug trial The development marks a 'watershed moment for psilocybin research' says the company's CEO Rowan DunneJanuary 18, 2023